We can't find the internet
Attempting to reconnect
12948.1;9 PFLS-LS
Synthetic Biology for the Discovery of Novel 11 B-HSD Inhibitors
Zusammenfassung
Synthetic Biology for the Discovery of Novel 11 B-HSD Inhibitors
Weitere Texte
Abstract
The enzyme 11â-hydroxysteroid dehydrogenase type 1 (11â-HSD1) acts as a cellular switch to mediate glucocorticoid action. Excessive cortisol production through 11â-HSD1 has been implicated in several diseases like metabolic syndrome, type II diabetes, obesity and skin aging. This project aims at the discovery of novel specific inhibitors of 11â-HSD1 using Evolva¿s Synthetic Biology Technology Platform. Alongside we will improve this technology in several aspects that will allow us to rebuild unknown biosynthetic pathways in yeast and efficiently identify and produce bioactive compounds for the healthcare industry.
Beteiligte
Eric Kübler
Kontaktperson
eric.kuebler@fhnw.ch
Fachhochschule Nordwestschweiz Eric Kübler Gründenstr. 40 4132 Muttenz BL CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2012-01-31
- Enddatum
- 2015-11-30
- Bewilligte Gesamtkosten
- CHF 377920.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%